Dr Saif Huda
About Saif Huda
Dr Saif Huda completed undergraduate medical training in Liverpool in 2005 and completed neurology specialist training at The Walton Centre in 2017. Between 2012-2015 he undertook a DPhil in neuroimmunology at The University of Oxford before completing a post-CCT fellowship in neuromyelitis optica in 2018.
Dr Huda is the clinical lead for the UK NMOSD highly specialised service. My team and I provide a multidisciplinary service for patients with NMOSD and myelin oligodendrocyte glycoprotein associated disease (MOGAD) across the United Kingdom. I am also a Multiple Sclerosis specialist and have expertise in antibody-mediated central nervous system disorders.
He provides a weekly MS clinic and acute ward referral service to Glan Clywd Hospital, North Wales. In addition to general neurology clinics he also holds a monthly CNS autoimmune clinic.
Dr Huda’s group’s research focuses on immune tolerance mechanisms and biomarkers in NMOSD and MOG-antibody associated disease, particularly clinical and serological biomarkers that help predict relapse risk and prognosis. They are also interested in immune tolerance mechanisms and identifying novel symptomatic therapies that can improve patient quality of life. Dr Huda is a principal investigator for several Phase III clinical trials in NMOSD, MOGAD, and autoimmune encephalitis.
Neuromyelitis optica spectrum disorders (NMOSD)
Multiple sclerosis (MS)
Antibody-mediated CNS disease
Neuromyelitis optica spectrum disorder (NMOSD)
Myelin oligodendrocyte glycoprotein associated disease (MOGAD)
Antibody-mediated central nervous system disorders
NMOSD and MOGAD - clinical and serological biomarkers that help predict relapse risk and prognosis
Immune tolerance mechanisms and identifying novel symptomatic therapies that can improve patient quality of life
Membership of professional regional and national bodies
Royal College of Physicians London
Association of British Neurologists
American Academy of Neurology
Page last updated: 14 July 2021